2m 2m 2m 2m 2m 2m 2m
MILESTONE PHARMA (MIST)
NASDAQ
$1.31+$0.03 (+2.58%)
Price as of Jun 03, 2026 7:58 PM EDT- $176.8MMarket Cap
- -22.42%1-Year Change
- BiotechnologyIndustry
MILESTONE PHARMA (MIST)
$1.31+$0.03 (+2.58%)
MIST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.28 | ||
Change | -$0.04 (-3.03%) | ||
Open | $1.34 | ||
High | $1.34 | ||
Low | $1.27 | ||
Previous Close | $1.32 | ||
Volume | 820,214 | ||
30-Day Average Volume | 1,491,287 | ||
1-Week Change | -8.57% | ||
1-Month Change | -31.55% | ||
1-Year Change | -22.42% | ||
3-Year Change | -65.96% | ||
5-Year Change | -76.68% | ||
Fundamentals | |||
Shares Outstanding | 124.5M | ||
Total Assets | $193.7M | ||
Market Cap | $176.8M | ||
Enterprise Value | $163.7M | ||
Period: QTR TTM FY | |||
Revenue | $238,000.00 | ||
Net Income | -$26.1M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$25.1M | ||
EBITDA | -$25.0M | ||
Net Working Capital | $171.3M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 688 | ||
P/B | 5 | ||
P/E | -7 | ||
PEG | N/A | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue